Corporation or
Pond )(TSX.V:POND), (OTCQB:PNDHF) an ESG company addressing global sustainability challenges of climate change and nutrition, is pleased to announce John M. Farah Jr, Ph.D has been appointed to the Board of Directors.
John M. Farah Jr, Ph.D has over 30 years of experience in health care and the biopharmaceutical industry. He is currently a senior clinical consultant with Veradigm, an Allscripts business, leveraging real-world data and real-world evidence for insights into challenges and opportunities in care of patients with chronic health conditions. He is also a member of the industry advisory board for the Coulter-Drexel Translational Research Partnership Program (Drexel University). John has advised clients in drug and biologic development and corporate partnering as Managing Director of his own consultancy and in market access and market research with agencies like rjSynergy. John began advising small to mid-sized firms after 19 years at Cephalon (now Teva) w
Pond Technologies Holdings Inc Appoints John M Farah Jr, Ph D to Board of Directors Strategic Appointment to Assist in Pond Biotech Expansion
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Pond Technologies Announces Engineering Contract with CSV Midstream Solutions Corp for Construction of an Algae Plant Utilizing CO2 from an On-Site Natural Gas Plant
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.